img

Global In-Vitro Diagnostics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global In-Vitro Diagnostics Market Research Report 2024

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
According to MRAResearch’s new survey, global In-Vitro Diagnostics market is projected to reach US$ 130080 million in 2033, increasing from US$ 105140 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In-Vitro Diagnostics market research.
The concentration of the market is relatively high, and the top 10 companies include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Becton Dickinson, BioMerieux, Sysmex, Hologic, Ortho Clinical Diagnostics, they occupied about 70% of whole market. North America dominates the market which occupied 41.39% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 15.74% of the whole market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In-Vitro Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
LifeScan
Qiagen
Wuhan Easy Diagnosis
Wondfo
KHB
Hotgen
Mindray
Sinocare
Getein Biotech
Segment by Type
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Other

Segment by Application


Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In-Vitro Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Tissue Diagnostics
1.2.3 Professional Diagnostic
1.2.4 Molecular Diagnostic
1.2.5 Diabetes Monitoring
1.2.6 Other
1.3 Market by Application
1.3.1 Global In-Vitro Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Oncology
1.3.5 Cardiology
1.3.6 HIV
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Diagnostics Market Perspective (2018-2033)
2.2 In-Vitro Diagnostics Growth Trends by Region
2.2.1 Global In-Vitro Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 In-Vitro Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 In-Vitro Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 In-Vitro Diagnostics Market Dynamics
2.3.1 In-Vitro Diagnostics Industry Trends
2.3.2 In-Vitro Diagnostics Market Drivers
2.3.3 In-Vitro Diagnostics Market Challenges
2.3.4 In-Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Diagnostics Players by Revenue
3.1.1 Global Top In-Vitro Diagnostics Players by Revenue (2018-2023)
3.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Diagnostics Revenue
3.4 Global In-Vitro Diagnostics Market Concentration Ratio
3.4.1 Global In-Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Diagnostics Revenue in 2022
3.5 In-Vitro Diagnostics Key Players Head office and Area Served
3.6 Key Players In-Vitro Diagnostics Product Solution and Service
3.7 Date of Enter into In-Vitro Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Diagnostics Breakdown Data by Type
4.1 Global In-Vitro Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global In-Vitro Diagnostics Forecasted Market Size by Type (2024-2033)
5 In-Vitro Diagnostics Breakdown Data by Application
5.1 Global In-Vitro Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global In-Vitro Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America In-Vitro Diagnostics Market Size (2018-2033)
6.2 North America In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America In-Vitro Diagnostics Market Size by Country (2018-2023)
6.4 North America In-Vitro Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Vitro Diagnostics Market Size (2018-2033)
7.2 Europe In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe In-Vitro Diagnostics Market Size by Country (2018-2023)
7.4 Europe In-Vitro Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific In-Vitro Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific In-Vitro Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific In-Vitro Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Vitro Diagnostics Market Size (2018-2033)
9.2 Latin America In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America In-Vitro Diagnostics Market Size by Country (2018-2023)
9.4 Latin America In-Vitro Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche In-Vitro Diagnostics Introduction
11.1.4 Roche Revenue in In-Vitro Diagnostics Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott In-Vitro Diagnostics Introduction
11.2.4 Abbott Revenue in In-Vitro Diagnostics Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 Danaher
11.3.1 Danaher Company Detail
11.3.2 Danaher Business Overview
11.3.3 Danaher In-Vitro Diagnostics Introduction
11.3.4 Danaher Revenue in In-Vitro Diagnostics Business (2018-2023)
11.3.5 Danaher Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers In-Vitro Diagnostics Introduction
11.4.4 Siemens Healthineers Revenue in In-Vitro Diagnostics Business (2018-2023)
11.4.5 Siemens Healthineers Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific In-Vitro Diagnostics Introduction
11.5.4 Thermo Fisher Scientific Revenue in In-Vitro Diagnostics Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Sysmex
11.6.1 Sysmex Company Detail
11.6.2 Sysmex Business Overview
11.6.3 Sysmex In-Vitro Diagnostics Introduction
11.6.4 Sysmex Revenue in In-Vitro Diagnostics Business (2018-2023)
11.6.5 Sysmex Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Detail
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux In-Vitro Diagnostics Introduction
11.7.4 BioMerieux Revenue in In-Vitro Diagnostics Business (2018-2023)
11.7.5 BioMerieux Recent Development
11.8 Ortho Clinical Diagnostics
11.8.1 Ortho Clinical Diagnostics Company Detail
11.8.2 Ortho Clinical Diagnostics Business Overview
11.8.3 Ortho Clinical Diagnostics In-Vitro Diagnostics Introduction
11.8.4 Ortho Clinical Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023)
11.8.5 Ortho Clinical Diagnostics Recent Development
11.9 Becton Dickinson
11.9.1 Becton Dickinson Company Detail
11.9.2 Becton Dickinson Business Overview
11.9.3 Becton Dickinson In-Vitro Diagnostics Introduction
11.9.4 Becton Dickinson Revenue in In-Vitro Diagnostics Business (2018-2023)
11.9.5 Becton Dickinson Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Detail
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories In-Vitro Diagnostics Introduction
11.10.4 Bio-Rad Laboratories Revenue in In-Vitro Diagnostics Business (2018-2023)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Hologic
11.11.1 Hologic Company Detail
11.11.2 Hologic Business Overview
11.11.3 Hologic In-Vitro Diagnostics Introduction
11.11.4 Hologic Revenue in In-Vitro Diagnostics Business (2018-2023)
11.11.5 Hologic Recent Development
11.12 LifeScan
11.12.1 LifeScan Company Detail
11.12.2 LifeScan Business Overview
11.12.3 LifeScan In-Vitro Diagnostics Introduction
11.12.4 LifeScan Revenue in In-Vitro Diagnostics Business (2018-2023)
11.12.5 LifeScan Recent Development
11.13 Qiagen
11.13.1 Qiagen Company Detail
11.13.2 Qiagen Business Overview
11.13.3 Qiagen In-Vitro Diagnostics Introduction
11.13.4 Qiagen Revenue in In-Vitro Diagnostics Business (2018-2023)
11.13.5 Qiagen Recent Development
11.14 Wuhan Easy Diagnosis
11.14.1 Wuhan Easy Diagnosis Company Detail
11.14.2 Wuhan Easy Diagnosis Business Overview
11.14.3 Wuhan Easy Diagnosis In-Vitro Diagnostics Introduction
11.14.4 Wuhan Easy Diagnosis Revenue in In-Vitro Diagnostics Business (2018-2023)
11.14.5 Wuhan Easy Diagnosis Recent Development
11.15 Wondfo
11.15.1 Wondfo Company Detail
11.15.2 Wondfo Business Overview
11.15.3 Wondfo In-Vitro Diagnostics Introduction
11.15.4 Wondfo Revenue in In-Vitro Diagnostics Business (2018-2023)
11.15.5 Wondfo Recent Development
11.16 KHB
11.16.1 KHB Company Detail
11.16.2 KHB Business Overview
11.16.3 KHB In-Vitro Diagnostics Introduction
11.16.4 KHB Revenue in In-Vitro Diagnostics Business (2018-2023)
11.16.5 KHB Recent Development
11.17 Hotgen
11.17.1 Hotgen Company Detail
11.17.2 Hotgen Business Overview
11.17.3 Hotgen In-Vitro Diagnostics Introduction
11.17.4 Hotgen Revenue in In-Vitro Diagnostics Business (2018-2023)
11.17.5 Hotgen Recent Development
11.18 Mindray
11.18.1 Mindray Company Detail
11.18.2 Mindray Business Overview
11.18.3 Mindray In-Vitro Diagnostics Introduction
11.18.4 Mindray Revenue in In-Vitro Diagnostics Business (2018-2023)
11.18.5 Mindray Recent Development
11.19 Sinocare
11.19.1 Sinocare Company Detail
11.19.2 Sinocare Business Overview
11.19.3 Sinocare In-Vitro Diagnostics Introduction
11.19.4 Sinocare Revenue in In-Vitro Diagnostics Business (2018-2023)
11.19.5 Sinocare Recent Development
11.20 Getein Biotech
11.20.1 Getein Biotech Company Detail
11.20.2 Getein Biotech Business Overview
11.20.3 Getein Biotech In-Vitro Diagnostics Introduction
11.20.4 Getein Biotech Revenue in In-Vitro Diagnostics Business (2018-2023)
11.20.5 Getein Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Tissue Diagnostics
Table 3. Key Players of Professional Diagnostic
Table 4. Key Players of Molecular Diagnostic
Table 5. Key Players of Diabetes Monitoring
Table 6. Key Players of Other
Table 7. Global In-Vitro Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global In-Vitro Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global In-Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global In-Vitro Diagnostics Market Share by Region (2018-2023)
Table 11. Global In-Vitro Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global In-Vitro Diagnostics Market Share by Region (2024-2033)
Table 13. In-Vitro Diagnostics Market Trends
Table 14. In-Vitro Diagnostics Market Drivers
Table 15. In-Vitro Diagnostics Market Challenges
Table 16. In-Vitro Diagnostics Market Restraints
Table 17. Global In-Vitro Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global In-Vitro Diagnostics Market Share by Players (2018-2023)
Table 19. Global Top In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2022)
Table 20. Ranking of Global Top In-Vitro Diagnostics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by In-Vitro Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players In-Vitro Diagnostics Product Solution and Service
Table 24. Date of Enter into In-Vitro Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global In-Vitro Diagnostics Revenue Market Share by Type (2018-2023)
Table 28. Global In-Vitro Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global In-Vitro Diagnostics Revenue Market Share by Type (2024-2033)
Table 30. Global In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global In-Vitro Diagnostics Revenue Market Share by Application (2018-2023)
Table 32. Global In-Vitro Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global In-Vitro Diagnostics Revenue Market Share by Application (2024-2033)
Table 34. North America In-Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America In-Vitro Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe In-Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe In-Vitro Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific In-Vitro Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific In-Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific In-Vitro Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America In-Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America In-Vitro Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa In-Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa In-Vitro Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche In-Vitro Diagnostics Product
Table 52. Roche Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Abbott Company Detail
Table 55. Abbott Business Overview
Table 56. Abbott In-Vitro Diagnostics Product
Table 57. Abbott Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 58. Abbott Recent Development
Table 59. Danaher Company Detail
Table 60. Danaher Business Overview
Table 61. Danaher In-Vitro Diagnostics Product
Table 62. Danaher Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 63. Danaher Recent Development
Table 64. Siemens Healthineers Company Detail
Table 65. Siemens Healthineers Business Overview
Table 66. Siemens Healthineers In-Vitro Diagnostics Product
Table 67. Siemens Healthineers Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 68. Siemens Healthineers Recent Development
Table 69. Thermo Fisher Scientific Company Detail
Table 70. Thermo Fisher Scientific Business Overview
Table 71. Thermo Fisher Scientific In-Vitro Diagnostics Product
Table 72. Thermo Fisher Scientific Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 73. Thermo Fisher Scientific Recent Development
Table 74. Sysmex Company Detail
Table 75. Sysmex Business Overview
Table 76. Sysmex In-Vitro Diagnostics Product
Table 77. Sysmex Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 78. Sysmex Recent Development
Table 79. BioMerieux Company Detail
Table 80. BioMerieux Business Overview
Table 81. BioMerieux In-Vitro Diagnostics Product
Table 82. BioMerieux Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 83. BioMerieux Recent Development
Table 84. Ortho Clinical Diagnostics Company Detail
Table 85. Ortho Clinical Diagnostics Business Overview
Table 86. Ortho Clinical Diagnostics In-Vitro Diagnostics Product
Table 87. Ortho Clinical Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 88. Ortho Clinical Diagnostics Recent Development
Table 89. Becton Dickinson Company Detail
Table 90. Becton Dickinson Business Overview
Table 91. Becton Dickinson In-Vitro Diagnostics Product
Table 92. Becton Dickinson Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 93. Becton Dickinson Recent Development
Table 94. Bio-Rad Laboratories Company Detail
Table 95. Bio-Rad Laboratories Business Overview
Table 96. Bio-Rad Laboratories In-Vitro Diagnostics Product
Table 97. Bio-Rad Laboratories Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 98. Bio-Rad Laboratories Recent Development
Table 99. Hologic Company Detail
Table 100. Hologic Business Overview
Table 101. Hologic In-Vitro Diagnostics Product
Table 102. Hologic Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 103. Hologic Recent Development
Table 104. LifeScan Company Detail
Table 105. LifeScan Business Overview
Table 106. LifeScan In-Vitro Diagnostics Product
Table 107. LifeScan Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 108. LifeScan Recent Development
Table 109. Qiagen Company Detail
Table 110. Qiagen Business Overview
Table 111. Qiagen In-Vitro Diagnostics Product
Table 112. Qiagen Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 113. Qiagen Recent Development
Table 114. Wuhan Easy Diagnosis Company Detail
Table 115. Wuhan Easy Diagnosis Business Overview
Table 116. Wuhan Easy Diagnosis In-Vitro Diagnostics Product
Table 117. Wuhan Easy Diagnosis Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 118. Wuhan Easy Diagnosis Recent Development
Table 119. Wondfo Company Detail
Table 120. Wondfo Business Overview
Table 121. Wondfo In-Vitro Diagnostics Product
Table 122. Wondfo Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 123. Wondfo Recent Development
Table 124. KHB Company Detail
Table 125. KHB Business Overview
Table 126. KHB In-Vitro Diagnostics Product
Table 127. KHB Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 128. KHB Recent Development
Table 129. Hotgen Company Detail
Table 130. Hotgen Business Overview
Table 131. Hotgen In-Vitro Diagnostics Product
Table 132. Hotgen Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 133. Hotgen Recent Development
Table 134. Mindray Company Detail
Table 135. Mindray Business Overview
Table 136. Mindray In-Vitro Diagnostics Product
Table 137. Mindray Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 138. Mindray Recent Development
Table 139. Sinocare Company Detail
Table 140. Sinocare Business Overview
Table 141. Sinocare In-Vitro Diagnostics Product
Table 142. Sinocare Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 143. Sinocare Recent Development
Table 144. Getein Biotech Company Detail
Table 145. Getein Biotech Business Overview
Table 146. Getein Biotech In-Vitro Diagnostics Product
Table 147. Getein Biotech Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 148. Getein Biotech Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-Vitro Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global In-Vitro Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Tissue Diagnostics Features
Figure 4. Professional Diagnostic Features
Figure 5. Molecular Diagnostic Features
Figure 6. Diabetes Monitoring Features
Figure 7. Other Features
Figure 8. Global In-Vitro Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global In-Vitro Diagnostics Market Share by Application: 2022 VS 2033
Figure 10. Diabetes Case Studies
Figure 11. Infectious Diseases Case Studies
Figure 12. Oncology Case Studies
Figure 13. Cardiology Case Studies
Figure 14. HIV Case Studies
Figure 15. Other Case Studies
Figure 16. In-Vitro Diagnostics Report Years Considered
Figure 17. Global In-Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global In-Vitro Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global In-Vitro Diagnostics Market Share by Region: 2022 VS 2033
Figure 20. Global In-Vitro Diagnostics Market Share by Players in 2022
Figure 21. Global Top In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by In-Vitro Diagnostics Revenue in 2022
Figure 23. North America In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America In-Vitro Diagnostics Market Share by Country (2018-2033)
Figure 25. United States In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe In-Vitro Diagnostics Market Share by Country (2018-2033)
Figure 29. Germany In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific In-Vitro Diagnostics Market Share by Region (2018-2033)
Figure 37. China In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America In-Vitro Diagnostics Market Share by Country (2018-2033)
Figure 45. Mexico In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa In-Vitro Diagnostics Market Share by Country (2018-2033)
Figure 49. Turkey In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Roche Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 52. Abbott Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 53. Danaher Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 54. Siemens Healthineers Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 56. Sysmex Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 57. BioMerieux Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 58. Ortho Clinical Diagnostics Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 59. Becton Dickinson Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 60. Bio-Rad Laboratories Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 61. Hologic Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 62. LifeScan Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 63. Qiagen Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 64. Wuhan Easy Diagnosis Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 65. Wondfo Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 66. KHB Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 67. Hotgen Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 68. Mindray Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 69. Sinocare Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 70. Getein Biotech Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed